Post-translationally modified vimentin, e.g., phosphorylation, ubiquitination, carbamylation, and citrullination, has been extensively studied and shown to be involved in several diseases including RA, systemic lupus erythematosus, and ankylosing spondylitis [45,46,47,48,49,50]. This evidence concerns the gene VIM and rheumatoid arthritis.